Cue Biopharma And ImmunoScape Announce Exclusive Collaboration And License Agreement; ImmunoScape To Cevelop A Seed-and-Boost Immunotherapy Combining Cue Biopharma's CUE-100 With ImmunoScape's TCRs
Author: Benzinga Newsdesk | November 06, 2025 08:02am